Sa1751 - A Phase 3 Study of Vedolizumab for Induction and Maintenance Therapy in Japanese Patients with Moderately to Severely Active Ulcerative Colitis
Watanabe, Mamoru, Motoya, Satoshi, Watanabe, Kenji, Ogata, Haruhiko, Kanai, Takanori, Matsui, Toshiyuki, Suzuki, Yasuo, Shikamura, Mitsuhiro, Igeta, Masataka, Oda, Kazunori, Hori, Tetsuharu, Araki, TaVolume:
154
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(18)31575-0
Date:
May, 2018
File:
PDF, 753 KB
english, 2018